Home Pharmaceuticals Cell Therapy Raw Materials Market Size, Trends & Growth Report by 2034

Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report By Product (Media, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers, Others), End Use (Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRPH57909DR
Last Updated: Dec, 2025
Pages: 110
Author: Debashree Bora
Format: PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Cell Therapy Raw Materials Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media
        1. By Value
      3. Sera
        1. By Value
      4. Cell Culture Supplements
        1. By Value
      5. Antibodies
        1. By Value
      6. Reagents & Buffers
        1. By Value
      7. Others
        1. By Value
    3. End Use
      1. Introduction
        1. End Use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. CROs & CMOs
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media
        1. By Value
      3. Sera
        1. By Value
      4. Cell Culture Supplements
        1. By Value
      5. Antibodies
        1. By Value
      6. Reagents & Buffers
        1. By Value
      7. Others
        1. By Value
    3. End Use
      1. Introduction
        1. End Use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. CROs & CMOs
        1. By Value
      4. Others
        1. By Value
    4. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media
          1. By Value
        3. Sera
          1. By Value
        4. Cell Culture Supplements
          1. By Value
        5. Antibodies
          1. By Value
        6. Reagents & Buffers
          1. By Value
        7. Others
          1. By Value
      2. End Use
        1. Introduction
          1. End Use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. CROs & CMOs
          1. By Value
        4. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media
        1. By Value
      3. Sera
        1. By Value
      4. Cell Culture Supplements
        1. By Value
      5. Antibodies
        1. By Value
      6. Reagents & Buffers
        1. By Value
      7. Others
        1. By Value
    3. End Use
      1. Introduction
        1. End Use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. CROs & CMOs
        1. By Value
      4. Others
        1. By Value
    4. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media
          1. By Value
        3. Sera
          1. By Value
        4. Cell Culture Supplements
          1. By Value
        5. Antibodies
          1. By Value
        6. Reagents & Buffers
          1. By Value
        7. Others
          1. By Value
      2. End Use
        1. Introduction
          1. End Use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. CROs & CMOs
          1. By Value
        4. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media
        1. By Value
      3. Sera
        1. By Value
      4. Cell Culture Supplements
        1. By Value
      5. Antibodies
        1. By Value
      6. Reagents & Buffers
        1. By Value
      7. Others
        1. By Value
    3. End Use
      1. Introduction
        1. End Use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. CROs & CMOs
        1. By Value
      4. Others
        1. By Value
    4. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media
          1. By Value
        3. Sera
          1. By Value
        4. Cell Culture Supplements
          1. By Value
        5. Antibodies
          1. By Value
        6. Reagents & Buffers
          1. By Value
        7. Others
          1. By Value
      2. End Use
        1. Introduction
          1. End Use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. CROs & CMOs
          1. By Value
        4. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media
        1. By Value
      3. Sera
        1. By Value
      4. Cell Culture Supplements
        1. By Value
      5. Antibodies
        1. By Value
      6. Reagents & Buffers
        1. By Value
      7. Others
        1. By Value
    3. End Use
      1. Introduction
        1. End Use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. CROs & CMOs
        1. By Value
      4. Others
        1. By Value
    4. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media
          1. By Value
        3. Sera
          1. By Value
        4. Cell Culture Supplements
          1. By Value
        5. Antibodies
          1. By Value
        6. Reagents & Buffers
          1. By Value
        7. Others
          1. By Value
      2. End Use
        1. Introduction
          1. End Use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. CROs & CMOs
          1. By Value
        4. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Media
        1. By Value
      3. Sera
        1. By Value
      4. Cell Culture Supplements
        1. By Value
      5. Antibodies
        1. By Value
      6. Reagents & Buffers
        1. By Value
      7. Others
        1. By Value
    3. End Use
      1. Introduction
        1. End Use By Value
      2. Biopharmaceutical & Pharmaceutical Companies
        1. By Value
      3. CROs & CMOs
        1. By Value
      4. Others
        1. By Value
    4. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Media
          1. By Value
        3. Sera
          1. By Value
        4. Cell Culture Supplements
          1. By Value
        5. Antibodies
          1. By Value
        6. Reagents & Buffers
          1. By Value
        7. Others
          1. By Value
      2. End Use
        1. Introduction
          1. End Use By Value
        2. Biopharmaceutical & Pharmaceutical Companies
          1. By Value
        3. CROs & CMOs
          1. By Value
        4. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Cell Therapy Raw Materials Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Merck KGaA
    3. Sartorius AG
    4. STEMCELL Technologies
    5. Lonza
    6. Miltenyi Biotec
    7. Bio-Techne
    8. BD
    9. GE HealthCare
    10. Corning Incorporated
    11. Sartorius CellGenix GmbH
    12. Charles River Laboratories
    13. ACROBiosystems
    14. Actylis
    15. RoosterBio, Inc.
    16. PromoCell
    17. Repligen Corporation
    18. Eppendorf SE
    19. PBS Biotech, Inc.
    20. Others
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

WhatsApp
Chat with us on WhatsApp
Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.